Search
for
Sort by
Research 31–60 of 1000+
- Male pattern baldness and incidence of prostate cancer
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
- High-throughput and direct measurement of androgen levels using turbulent flow chromatography liquid chromatography-triple quadrupole mass spectrometry (TFC-LC-TQMS) to discover chemicals that modulate dihydrotestosterone production in human prostate cancer cells
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Hair loss at 20 associated with prostate cancer risk later in life
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Prostate cancer prevention
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Baldness, benign prostate hyperplasia, prostate cancer and androgen levels
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Hormonal prevention of prostate cancer
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer